✦ LIBER ✦

Evolving targets for risk reduction in diabetes

✍ Scribed by Gregory M. Caputo; Joel B. Braunstein; Roger S. Blumenthal

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Who Should We Target for Diabetes Preven

✍ Susann Blüher; Jana Markert; Sabine Herget; Thomas Yates; Melanie Davis; Gabriel 📂 Article 📅 2012 🏛 Current Science Inc. 🌐 English ⚖ 198 KB

Targeting dyslipidemia—the key to CHD ri

✍ D. John Betteridge; Robert S. Rosenson 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Diabetes and obesity: therapeutic target

✍ Kevin Niswender 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 636 KB

Sleep-Time Blood Pressure as a Therapeut

✍ Hermida, Ramón C.; Ayala, Diana E.; Mojón, Artemio; Fernández, José R. 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 265 KB

Drugs for cardiovascular risk reduction

✍ David S. H. Bell 📂 Article 📅 2001 🏛 Current Science Inc. 🌐 English ⚖ 275 KB

DFMO: Targeted risk reduction therapy fo

✍ Christina M. Laukaitis; Eugene W. Gerner 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 346 KB